Bonesupport Holding AB (publ) (OM: BONEX)
Health Care · Biotechnology · SE
Skr242.60
+8.98% today · -26.6% 1Y
Bonesupport Holding AB (publ) (OM: BONEX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.45B and employs 171 people.
Over the last twelve months the share price has lost 26.6%, trading between 165.00 and 306.80.
Tweenvest scores Bonesupport Holding AB (publ) across four factors: quality 71/100, value 46/100, growth 100/100. Its strongest factor is growth.
BONEX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.45B
- Revenue (TTM)
- $132.73M
- P/E
- 69.38
- EPS
- 3.21
- Dividend yield
- —
- Beta (5Y)
- 0.31
- 52-week high
- Skr306.80
- 52-week low
- Skr165.00
- Avg volume (3M)
- —
- Shares outstanding
- 65.49M
- Employees
- 171
- Next earnings
- —
About Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.
- ISIN
- SE0009858152
- Founded
- 1999
- Listed since
- Jun 21, 2017
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Staidson (Beijing) BioPharmaceuticals Co., Ltd.SZSE: 300204 | $1.47B | CN¥20.66 | +1.08% |
| Hugel, Inc.KOSDAQ: A145020 | $1.47B | ₩182,800.00 | +1.50% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.46B | $4.17 | -7.13% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.46B | ₩42,850.00 | -0.35% |
| Nektar TherapeuticsNasdaqCM: NKTR | $1.41B | $40.17 | -2.43% |
| Inhibrx Biosciences, Inc.NasdaqGS: INBX | $1.40B | $90.67 | -4.57% |
| Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403 | $1.39B | CN¥9.96 | -0.99% |
| AnaptysBio, Inc.NasdaqGS: ANAB | $1.37B | $46.08 | +0.28% |
Figures last refreshed Oct 11, 2026.